文献速递胸部肿瘤

辛伐他汀对Lewis肺癌细胞株增殖、侵袭及放射敏感性的影响

[Effects of simvastatin on the proliferation, invasion and radiosensitivity in Lewis lung cancer cell line].
PubMed 文献 · Zhonghua Zhong Liu Za Zhi · 2017-01-01

研究在体外用MTT法、Matrigel侵袭迁移实验及Western blot检测辛伐他汀对Lewis肺癌细胞增殖、侵袭、p38活性及p-p38、MKP-1、RhoA、MMP-2表达的影响,并在C57BL/6小鼠肺癌移植瘤模型中比较对照组、辛伐他汀组、单纯放疗组和联合治疗组的肿瘤质量、体积及肺转移结节。结果显示辛伐他汀抑制细胞增殖和侵袭、降低p38活性与p-p38表达、下调RhoA和MMP-2并上调MKP-1,联合放疗可抑制肿瘤生长和转移并提高放疗疗效。

要点

  • 辛伐他汀可抑制Lewis肺癌细胞增殖和侵袭,并呈浓度依赖性。
  • 辛伐他汀降低p38活性和p-p38表达,下调RhoA、MMP-2并上调MKP-1。
  • 辛伐他汀联合放疗可抑制小鼠移植瘤生长和肺转移,提高放疗疗效。

核心结论

  • 辛伐他汀通过抑制p38活性和p-p38表达抑制Lewis细胞株增殖,并通过下调RhoA和MMP-2表达降低细胞侵袭和运动能力。
  • 辛伐他汀与放疗联合可抑制肿瘤生长和转移,协同提高放疗疗效。

研究设计与样本

  • 体外实验采用MTT法检测辛伐他汀对Lewis肺癌细胞增殖的抑制作用,Matrigel侵袭和迁移实验测定细胞侵袭和运动能力,p38活性检测试剂盒测定p38活性,Western blot分析p-p38、MKP-1、RhoA和MMP-2表达。
  • 建立C57BL/6小鼠肺癌移植瘤模型,随机分为对照组、辛伐他汀组、单纯放疗组和联合治疗组,接种后27天处死小鼠,比较肿瘤质量、体积和肺转移结节。

主要发现

  • 0、10、20、30 μmol/L辛伐他汀组细胞增殖率分别为100%、(87.0±9.0)%、(76.5±8.1)%和(67.0±7.3)%(P<0.05)。
  • 上述各组每视野侵袭细胞数分别为298±30、251±26、207±20和132±19(P<0.05)。
  • 上述各组细胞内p38活性分别为100%、(83.1±8.8)%、(70.2±8.2)%和(59.0±6.4)%,p-p38相对表达量分别为100%、(76.2±6.7)%、(56.4±5.4)%和(36.5±3.2)%。
  • 上述各组RhoA表达分别为100%、(80.1±5.3)%、(55.3±6.2)%和(38.6±4.8)%,MMP-2表达分别为100%、(89.6±8.6)%、(51.9±4.7)%和(42.7±3.1)%,MKP-1表达分别为100%、(136.5±12.2)%、(168.8±15.3)%和(187.7±13.4)%(均P<0.05)。
  • 对照组、辛伐他汀组、单纯放疗组和联合治疗组肺转移结节数分别为6.24±1.09、3.07±0.71、5.09±1.16和2.43±0.53,肿瘤质量分别为3.12±0.68 g、1.96±0.62 g、2.65±0.38 g和1.12±0.43 g(均P<0.05)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Objective: To investigate the effects of simvastatin on proliferation, invasion and radiosensitivity of mouse Lewis lung cancer cell line in vitro. Methods: The inhibitory effects of simvastatin on proliferation of Lewis lung cancer cells were detected by MTT assay. Matrigel invasion and migration assay was used to determine the invasion and motility ability of the Lewis cells. P38 activity was measured by p38 activity detection kit, and the expressions of p-p38, MKP-1, RhoA and MMP-2 were analyzed by Western blot. Lung cancer xenograft model was established in C57BL/6 mice. The mice were randomly divided into control group, simvastatin group, radiotherapy alone group and combined treatment group. The mice were killed 27 days after inoculation. The tumor mass, volume and lung metastatic nodules in the mice were compared. Results: The cell proliferation rates of 0 μmol/L, 10 μmol/L, 20 μmol/L and 30 μmol/L simvastatin groups were 100%, (87.0±9.0)%, (76.5±8.1)% and (67.0±7.3)%, respectively (P<0.05). Invasive cell numbers of the above groups were 298±30, 251±26, 207±20 and 132±19 per field, respectively (P<0.05). The intracellular p38 activities were 100%, (83.1±8.8)%, (70.2±8.2)% and (59.0±6.4)%, respectively. The relative expressions of p-p38 were 100%, (76.2±6.7)%, (56.4±5.4)% and (36.5±3.2)%, respectively. The expressions of RhoA were 100%, (80.1±5.3)%, (55.3±6.2)% and (38.6±4.8)%, respectively. The expressions of MMP-2 were 100%, (89.6±8.6)%, (51.9±4.7)% and (42.7±3.1)%, respectively, while the expressions of MKP-1 were 100%, (136.5±12.2)%, (168.8±15.3)% and (187.7±13.4)%, respectively (all P<0.05). Lung metastatic nodules and mass in the control, simvastatin, radiotherapy group and combined treatment groups were 6.24±1.09, 3.07±0.71 g, 5.09±1.16, 2.43±0.53 g, 3.12±0.68, 1.96±0.62 g and 2.65±0.38, 1.12±0.43 g, respectively (all P<0.05). The tumor inhibition rates were 39.0%, 48.1% and 26.5%, respectively, in the radiotherapy alone, combined treatment and simvastatin groups (all P<0.05). Conclusions: Simvastatin inhibits the proliferation of Lewis cell line by inhibiting the activity of p38 and expression of p-p38. Meanwhile, simvastatin reduces the invasion and motility of Lewis cell line through down-regulating the expression of RhoA and MMP-2. When combined with radiotherapy, simvastatin can inhibit tumor growth and metastasis, and improve the treatment efficacy of radiotherapy synergistically.

来源:Zhonghua Zhong Liu Za Zhi,查看原文。版权归原作者所有。

引用

  1. Yu SF, Cheng J, Geng S, et al. [Effects of simvastatin on the proliferation, invasion and radiosensitivity in Lewis lung cancer cell line]. Zhonghua Zhong Liu Za Zhi. 2017. PMID: 28550662. doi:10.3760/cma.j.issn.0253-3766.2017.04.002

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。